Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Long-Term Debt Repayments (2020 - 2023)

Neuronetics (STIM) has disclosed Long-Term Debt Repayments for 2 consecutive years, with $1.2 million as the latest value for Q1 2023.

  • Quarterly Long-Term Debt Repayments changed N/A to $1.2 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2023, changed N/A year-over-year, with the annual reading at $211000.0 for FY2025, 99.65% down from the prior year.
  • Long-Term Debt Repayments for Q1 2023 was $1.2 million at Neuronetics, down from $6.4 million in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $32.5 million in Q1 2020, with the low at $1.2 million in Q1 2023.